Arkos Global Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Arkos Global Advisors's BSX Position: Q2 2026 in Review
Arkos Global Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,962 shares — an estimated $249K sold.
Arkos Global Advisors first reported a position in BSX in Q1 2020 and held it in 25 quarters. The position peaked at $914K in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Arkos Global Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Arkos Global Advisors sold 3,962 Boston Scientific shares in Q2 2026, an estimated $249K.
- Arkos Global Advisors first reported a position in Boston Scientific in Q1 2020 and held it in 25 quarters.
- Arkos Global Advisors's Boston Scientific position peaked at $914K in Q3 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Arkos Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.